Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

1.

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.

Weber MS, Prod'homme T, Patarroyo JC, Molnarfi N, Karnezis T, Lehmann-Horn K, Danilenko DM, Eastham-Anderson J, Slavin AJ, Linington C, Bernard CC, Martin F, Zamvil SS.

Ann Neurol. 2010 Sep;68(3):369-83. doi: 10.1002/ana.22081.

2.

Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders.

Lehmann-Horn K, Schleich E, Hertzenberg D, Hapfelmeier A, Kümpfel T, von Bubnoff N, Hohlfeld R, Berthele A, Hemmer B, Weber MS.

J Neuroinflammation. 2011 Oct 26;8:146. doi: 10.1186/1742-2094-8-146.

3.

Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.

Fissolo N, Costa C, Nurtdinov RN, Bustamante MF, Llombart V, Mansilla MJ, Espejo C, Montalban X, Comabella M.

J Neuroinflammation. 2012 Jun 22;9:139. doi: 10.1186/1742-2094-9-139.

4.

Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.

Martinez-Pasamar S, Abad E, Moreno B, Velez de Mendizabal N, Martinez-Forero I, Garcia-Ojalvo J, Villoslada P.

BMC Syst Biol. 2013 Apr 26;7:34. doi: 10.1186/1752-0509-7-34.

5.

MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.

Molnarfi N, Schulze-Topphoff U, Weber MS, Patarroyo JC, Prod'homme T, Varrin-Doyer M, Shetty A, Linington C, Slavin AJ, Hidalgo J, Jenne DE, Wekerle H, Sobel RA, Bernard CC, Shlomchik MJ, Zamvil SS.

J Exp Med. 2013 Dec 16;210(13):2921-37. doi: 10.1084/jem.20130699. Epub 2013 Dec 9.

6.

Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.

Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z.

J Neurosci Res. 2005 Mar 1;79(5):680-93.

PMID:
15682385
7.

T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.

Zheng H, Zhang H, Liu F, Qi Y, Jiang H.

Immunol Lett. 2014 Jan-Feb;157(1-2):38-44. doi: 10.1016/j.imlet.2013.11.001. Epub 2013 Nov 9.

PMID:
24220208
8.

Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.

Chen SJ, Wang YL, Lo WT, Wu CC, Hsieh CW, Huang CF, Lan YH, Wang CC, Chang DM, Sytwu HK.

Clin Exp Immunol. 2010 Nov;162(2):210-23.

9.

Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.

Tseveleki V, Tselios T, Kanistras I, Koutsoni O, Karamita M, Vamvakas SS, Apostolopoulos V, Dotsika E, Matsoukas J, Lassmann H, Probert L.

Exp Neurol. 2015 May;267:254-67. doi: 10.1016/j.expneurol.2014.10.019. Epub 2014 Oct 30.

PMID:
25447934
10.

Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis.

Williams JL, Kithcart AP, Smith KM, Shawler T, Cox GM, Whitacre CC.

J Neuroimmunol. 2011 May;234(1-2):84-92. doi: 10.1016/j.jneuroim.2011.02.008. Epub 2011 Apr 3.

11.

Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.

Isaksson M, Ardesjö B, Rönnblom L, Kämpe O, Lassmann H, Eloranta ML, Lobell A.

Eur J Immunol. 2009 Oct;39(10):2925-35. doi: 10.1002/eji.200839179.

12.

Depletion of CD4(+)CD25(+) T cells exacerbates experimental autoimmune encephalomyelitis induced by mouse, but not rat, antigens.

Akirav EM, Bergman CM, Hill M, Ruddle NH.

J Neurosci Res. 2009 Nov 15;87(15):3511-9. doi: 10.1002/jnr.21981.

13.
14.

Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.

Rynda-Apple A, Huarte E, Maddaloni M, Callis G, Skyberg JA, Pascual DW.

Eur J Immunol. 2011 Feb;41(2):313-23. doi: 10.1002/eji.201041104. Epub 2010 Dec 29.

15.

MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.

Mony JT, Khorooshi R, Owens T.

Mult Scler. 2014 Sep;20(10):1312-21. doi: 10.1177/1352458514524086. Epub 2014 Feb 19.

PMID:
24552747
16.

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.

Rostami A, Ciric B.

J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8. Review.

17.

Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.

Matsushita T, Horikawa M, Iwata Y, Tedder TF.

J Immunol. 2010 Aug 15;185(4):2240-52. doi: 10.4049/jimmunol.1001307. Epub 2010 Jul 12.

18.

Secondary B cell receptor diversification is necessary for T cell mediated neuro-inflammation during experimental autoimmune encephalomyelitis.

Galicia G, Boulianne B, Pikor N, Martin A, Gommerman JL.

PLoS One. 2013 Apr 22;8(4):e61478. doi: 10.1371/journal.pone.0061478. Print 2013.

19.

A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells.

Anderson AC, Chandwaskar R, Lee DH, Sullivan JM, Solomon A, Rodriguez-Manzanet R, Greve B, Sobel RA, Kuchroo VK.

J Immunol. 2012 Mar 1;188(5):2084-92. doi: 10.4049/jimmunol.1102186. Epub 2012 Jan 25.

20.
Items per page

Supplemental Content

Write to the Help Desk